In 2014, he was ranked 47 on Harvard Business Review's "Best Performing CEOs in the World". His track record for leadership continued as he served as President and Chief Operating Officer for Watson Pharmaceuticals (2001-2004), President of Global Country Operations for Pharmacia's North American business (2000-2001), and President of Searle's US Operations (1997-2000). During his 15-year career at Novartis Pharmaceuticals, he and his teams successfully launched the pharmaceutical products Lotrel ®, Divovan ®, and Celebrex ®. Mr. Papa currently serves on the Board of Prometheus Biosciences and had been a previous member of the Boards for the UConn Foundation and Smith & Nephew.